Long-term remission of extramedullary relapse from acute promyelocytic leukemia after treatment with arsenic trioxide, intrathecal chemotherapy, and brain irradiation.
Farhat
Mohamed
M
Rush University Medical Center, Chicago, IL 60612, USA. mohamed_farhat@rush.edu
Venugopal
Parameswaran
P
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D000077237:Arsenic Trioxide; D001152:Arsenicals / Q000008:administration & dosage*; D016371:Cranial Irradiation; D003630:Daunorubicin / Q000008:administration & dosage; D004428:Ear Neoplasms / Q000134:cerebrospinal fluid / Q000000981:diagnostic imaging / Q000235:genetics / Q000556:secondary / Q000628:therapy*; D006801:Humans; D007278:Injections, Spinal; D015479:Leukemia, Myelomonocytic, Acute / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics / Q000473:pathology; D008297:Male; D010087:Oxides / Q000008:administration & dosage*; D011859:Radiography; D012074:Remission Induction; D023981:Sarcoma, Myeloid / Q000134:cerebrospinal fluid / Q000000981:diagnostic imaging / Q000209:etiology / Q000235:genetics / Q000628:therapy*; D014212:Tretinoin / Q000008:administration & dosage
D001152:Arsenicals; D010087:Oxides; D014212:Tretinoin; D000077237:Arsenic Trioxide; D003630:Daunorubicin